ADCK2 and non-small cell lung carcinoma: Bioinformatic analyses of NSCLC patient data revealed a negative correlation between ADCK2 expression and overall survival, along with anti-PD-1/PD-L1 therapeutic response, suggesting a potential prognostic role.